BRAF status of follicular variant of papillary thyroid carcinoma and its relationship to its clinical and cytological features

Thyroid

Volumn 20, Issue 11, 2010, Pages 1263-1270

  Proietti, Agnese ^a   Giannini, Riccardo ^a   Ugolini, Clara ^a   Miccoli, Mario ^a   Fontanini, Gabriella ^a   Di Coscio, Giancarlo ^b   Romani, Rossana ^b   Berti, Piero ^a   Miccoli, Paolo ^a   Basolo, Fulvio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CLINICAL FEATURE; CYTODIAGNOSIS; DNA SEQUENCE; FEMALE; FOLLICULAR VARIANT OF PAPILLARY THYROID; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; CARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS B-RAF; THYROID GLAND; THYROID NEOPLASMS; THYROID NODULE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78249233270     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0283     Document Type: Article

References (26)

1. Rivera M, Tuttle RM, Patel S, Shaha A, Shah JP, Ghossein RA 2009 Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes histologic growth pattern. Thyroid 19:119-127.
2. Kesmodel SB, Terhune KP, Canter RJ, Mandel SJ, Li Volsi VA, Baloch ZW, Fraker DL 2003 The diagnostic dilemma of follicular variant of papillary thyroid carcinoma. Surgery 134:1005-1012.
3. Arora N, Scognamiglio T, Zhu B, Fahey TJ 2008 Do benign thyroid nodules have malignant potential? An evidencebased review. World J Surg 32:1237-1246.
4. Liou MJ, Chan EC, Lin JD, Liu FH, Chao TC 2003 Human telomerase reverse transcriptase (hTERT) gene expression in FNA samples from thyroid neoplasms. Cancer Lett 191:223-227.
5. Torregrossa L, Faviana P, Filice ME, Materazzi G, Miccoli P, Vitti P, Fontanini G, Melillo RM, Santoro M, Basolo F 2010 CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1. Thyroid 20:495-504.
6. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey TJ 3rd 2003 Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9:1792-1800.
7. Chen YT, Kitabayashi N, Zhou XK, Fahey TJ 3rd, Scognamiglio T 2008 MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Mod Pathol 21:1139-1146.
8. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G, Elisei R, Santoro M, Miccoli P, Basolo F 2007 Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92:4085-4090.
9. Rago T, Di Coscio G, Basolo F, Scutari M, Elisei R, Berti P, Miccoli P, Romani R, Faviana P, Pinchera A, Vitti P 2007 Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol 66:13-20.
10. Watkinson JC; British Thyroid Association 2004. The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun 25:897-900.
11. Cibas ES, Ali SZ 2009 The Bethesda system for reporting thyroid cytopathology. Thyroid 19:1159-1165.
12. Verhulst P, Devos P, Aubert S, Buob D, Cranshaw I, Do Cao C, Pattou F, Carnaille B, Wemeau JL, Leteurtre E 2008 A score based on microscopic criteria proposed for analysis of papillary carcinoma of the thyroid. Virchows Arch 452:233-240.
13. Li Volsi VA, Albores-Saavedra J 2004 Papillary carcinoma. In: IARC WHO Classification of Tumours. Pathology and Genetics. Tumours of Endocrine Organs. Eds: Deiellis R, Lloyo RV, Heite PU, Eng C. Lyon, pp 57-66.
14. Rosai J, Carcangiu ML 1993 Tumors of the thyroid gland. Atlas of tumor pathology, series 3, vol 5. Armed Forced Institute of Pathology. Washington, DC.
15. Liu J, Singh B, Tallini G, Carlson DL, Katabi N, Shaha A, Tuttle RM, Ghossein RA 2006 Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer 107:1255-1264.
16. Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL, Chan JK, De Lellis RA, Harach HR, Kakudo K, Li Volsi VA, Rosai J, Sebo TJ, Sobrinho-Simoes M, Wenig BM, Lae ME 2004 Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28:1336-1340.
17. Elsheikh TM, Asa SL, Chan JK, De Lellis RA, Heffess CS, LiVolsi VA, Wenig BM 2008 Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 130:736-744.
18. Layfield LJ, Morton MJ, Cramer HM, Hirschowitz S 2009 Implications of the proposed thyroid fine-needle aspiration category of "follicular lesion of undetermined significance": A five-year multi-institutional analysis. Diagn Cytopathol 37:710-714.
19. Mihai R, Parker AJ, Roskell D, Sadler GP 2009 One in four patients with follicular thyroid cytology (THY3) has a thyroid carcinoma. Thyroid 19:33-37.
20. Tielens ET, Sherman SI, Hruban RH, Ladenson PW 1994 Follicular variant of papillary thyroid carcinoma. A clinicopathologic study. Cancer 73:424-431.
21. Deveci MS, Deveci G, LiVolsi VA, Baloch ZW 2006 Fineneedle aspiration of follicular lesions of the thyroid. Diagnosis and follow-Up. Cytojournal 3:9.
22. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S, Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW 2005 BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90:6373-6379.
23. Oler G, Cerutti JM 2009 High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer 115:972-980.
24. Costa AM, Herrero A, Fresno MF, Heymann J, Alvarez JA, Cameselle-Teijeiro J, García-Rostán G 2008 BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma. Clin Endocrinol 68:618-634.
25. Nikiforov YE, Steward DL, Robinson-Smith TM, Haugen BR, Klopper JP, Zhu Z, Fagin JA, Falciglia M, Weber K, Nikiforova MN 2009 Molecular testing for mutations in improving the fine needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab 94:2092-2098.
26. Nikiforova MN, Chiosea SI, Nikiforov YE 2009 MicroRNA expression profiles in thyroid tumors. Endocr Pathol 20:85-91.